Statement of Changes in Beneficial Ownership (4)
August 18 2014 - 10:11AM
Edgar (US Regulatory)
X0306
4
2014-08-15
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001522478
FREEMAN KEVIN D
C/O GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BLVD, STE 240
NORCROSS
GA
30071
1
0
0
0
Common Stock
2014-08-15
4
P
0
1000
4.70
A
3917
D
/s/ Jack W. Callicutt, as power of attorney for Kevin D. Freeman
2014-08-18
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2023 to Mar 2024